Abstract
High levels of conversion of 14C-labelled pristinamycin IIB (PIIB) to pristinamycin IIA (PIIA) were obtained in vivo in Streptomyces pristinaespiralis and in some other streptogramin A producers. This established that PIIB was an intermediate on the pathway to PIIA. In addition, in vitro studies with cell-free protein preparations demonstrated that the oxidation of PIIB to PIIA is a complex process requiring NADH, riboflavin 5'-phosphate (FMN), and molecular oxygen. Two enzymes were shown to be necessary to catalyze this reaction. Both were purified to homogeneity from S. pristinaespiralis by a coupled enzyme assay based on the formation of PIIA and by requiring addition of the complementing enzyme. One enzyme was purified about 3,000-fold by a procedure including a decisive affinity chromatography step on FMN-agarose. It was shown to be a NADH:FMN oxidoreductase (E.C. 1.6.8.1.) (hereafter called FMN reductase), providing reduced FMN (FMNH2) to the more abundant second enzyme. The latter was purified only 160-fold and was called PIIA synthase. Our data strongly suggest that this enzyme catalyzes a transient hydroxylation of PIIB by molecular oxygen immediately followed by a dehydration leading to PIIA. The native PIIA synthase consists of two different subunits with Mrs of around 50,000 and 35,000, as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, while the FMN reductase seems to be a monomer with a Mr of around 28,000 and containing one molecule of tightly bound FMN. Stepwise Edman degradation of the entire polypeptides or some of their trypsin-digested fragments provided amino acid sequences for the two isolated proteins.
Full Text
The Full Text of this article is available as a PDF (278.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Cocito C. Antibiotics of the virginiamycin family, inhibitors which contain synergistic components. Microbiol Rev. 1979 Jun;43(2):145–192. doi: 10.1128/mr.43.2.145-192.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crooy P., De Neys R. Virginiamycin: nomenclature. J Antibiot (Tokyo) 1972 Jun;25(6):371–372. doi: 10.7164/antibiotics.25.371. [DOI] [PubMed] [Google Scholar]
- Duane W., Hastings J. W. Flavin mononucleotide reductase of luminous bacteria. Mol Cell Biochem. 1975 Jan 31;6(1):53–64. doi: 10.1007/BF01731866. [DOI] [PubMed] [Google Scholar]
- Fontecave M., Eliasson R., Reichard P. NAD(P)H:flavin oxidoreductase of Escherichia coli. A ferric iron reductase participating in the generation of the free radical of ribonucleotide reductase. J Biol Chem. 1987 Sep 5;262(25):12325–12331. [PubMed] [Google Scholar]
- Ghisla S., Massey V. Mechanisms of flavoprotein-catalyzed reactions. Eur J Biochem. 1989 Apr 15;181(1):1–17. doi: 10.1111/j.1432-1033.1989.tb14688.x. [DOI] [PubMed] [Google Scholar]
- Hastings J. W., Nealson K. H. Bacterial bioluminescence. Annu Rev Microbiol. 1977;31:549–595. doi: 10.1146/annurev.mi.31.100177.003001. [DOI] [PubMed] [Google Scholar]
- Inouye S. NAD(P)H-flavin oxidoreductase from the bioluminescent bacterium, Vibrio fischeri ATCC 7744, is a flavoprotein. FEBS Lett. 1994 Jun 27;347(2-3):163–168. doi: 10.1016/0014-5793(94)00528-1. [DOI] [PubMed] [Google Scholar]
- Jablonski E., DeLuca M. Purification and properties of the NADH and NADPH specific FMN oxidoreductases from Beneckea harveyi. Biochemistry. 1977 Jun 28;16(13):2932–2936. doi: 10.1021/bi00632a020. [DOI] [PubMed] [Google Scholar]
- Lei B., Liu M., Huang S., Tu S. C. Vibrio harveyi NADPH-flavin oxidoreductase: cloning, sequencing and overexpression of the gene and purification and characterization of the cloned enzyme. J Bacteriol. 1994 Jun;176(12):3552–3558. doi: 10.1128/jb.176.12.3552-3558.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PREUDHOMME J., BELLOC A., CHARPENTIE Y., TARRIDEC P. UN ANTIBIOTIQUE FORM'E DE DEUX GROUPES DE COMPOSANTS 'A SYNERGIE D'ACTION: LA PRISTINAMYCINE. C R Hebd Seances Acad Sci. 1965 Jan 25;260:1309–1312. [PubMed] [Google Scholar]
- Preud'homme J., Tarridec P., Belloc A. 90. Pristinamycine isolement, caractérisation et identification des constituants. Bull Soc Chim Fr. 1968 Feb;2:585–591. [PubMed] [Google Scholar]
- Schlumbohm W., Keller U. Chromophore activating enzyme involved in the biosynthesis of the mikamycin B antibiotic etamycin from Streptomyces griseoviridus. J Biol Chem. 1990 Feb 5;265(4):2156–2161. [PubMed] [Google Scholar]
- Uetz T., Schneider R., Snozzi M., Egli T. Purification and characterization of a two-component monooxygenase that hydroxylates nitrilotriacetate from "Chelatobacter" strain ATCC 29600. J Bacteriol. 1992 Feb;174(4):1179–1188. doi: 10.1128/jb.174.4.1179-1188.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watanabe H., Hastings J. W. Specificities and properties of three reduced pyridine nucleotide-flavin mononucleotide reductases coupling to bacterial luciferase. Mol Cell Biochem. 1982 May 14;44(3):181–187. doi: 10.1007/BF00238506. [DOI] [PubMed] [Google Scholar]
- Zenno S., Saigo K., Kanoh H., Inouye S. Identification of the gene encoding the major NAD(P)H-flavin oxidoreductase of the bioluminescent bacterium Vibrio fischeri ATCC 7744. J Bacteriol. 1994 Jun;176(12):3536–3543. doi: 10.1128/jb.176.12.3536-3543.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]